In addition to IV-tPA treatment, the former model included the following variables: age, initial systolic blood pressure, diabetes, sex, baseline NIHSS score, prior stroke, and symptom onset to treatment time; as well as interaction terms: treatment with blood pressure, sex, prior stroke, and onset to treatment time, and age with NIHSS. The gene discussed is PLAT; the disease is Stroke.